11-3667429-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_020402.4(CHRNA10):c.698G>A(p.Arg233His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000009 in 1,444,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000090 ( 0 hom. )
Consequence
CHRNA10
NM_020402.4 missense
NM_020402.4 missense
Scores
1
3
10
Clinical Significance
Conservation
PhyloP100: 1.34
Genes affected
CHRNA10 (HGNC:13800): (cholinergic receptor nicotinic alpha 10 subunit) Predicted to enable acetylcholine-gated cation-selective channel activity. Acts upstream of or within positive regulation of cytosolic calcium ion concentration. Predicted to be located in membrane. Predicted to be active in cholinergic synapse and neuron projection. Predicted to be integral component of postsynaptic specialization membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1402672).
BP6
Variant 11-3667429-C-T is Benign according to our data. Variant chr11-3667429-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3267152.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA10 | NM_020402.4 | c.698G>A | p.Arg233His | missense_variant | 4/5 | ENST00000250699.2 | NP_065135.2 | |
CHRNA10 | NM_001303034.2 | c.80G>A | p.Arg27His | missense_variant | 4/5 | NP_001289963.1 | ||
CHRNA10 | NM_001303035.2 | c.80G>A | p.Arg27His | missense_variant | 4/5 | NP_001289964.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA10 | ENST00000250699.2 | c.698G>A | p.Arg233His | missense_variant | 4/5 | 1 | NM_020402.4 | ENSP00000250699.2 | ||
CHRNA10 | ENST00000534359.1 | c.151G>A | p.Ala51Thr | missense_variant | 4/5 | 1 | ENSP00000437107.1 | |||
CHRNA10 | ENST00000526599.1 | n.*469G>A | non_coding_transcript_exon_variant | 4/5 | 1 | ENSP00000432757.1 | ||||
CHRNA10 | ENST00000526599.1 | n.*469G>A | 3_prime_UTR_variant | 4/5 | 1 | ENSP00000432757.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000452 AC: 10AN: 221112Hom.: 0 AF XY: 0.0000326 AC XY: 4AN XY: 122596
GnomAD3 exomes
AF:
AC:
10
AN:
221112
Hom.:
AF XY:
AC XY:
4
AN XY:
122596
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000900 AC: 13AN: 1444280Hom.: 0 Cov.: 32 AF XY: 0.00000557 AC XY: 4AN XY: 718618
GnomAD4 exome
AF:
AC:
13
AN:
1444280
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
718618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift4G
Benign
T
Vest4
MutPred
Gain of glycosylation at A51 (P = 0.0035);
MVP
ClinPred
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at